Grown Rogue International (GRUSF) Goodwill (2021 - 2022)
Grown Rogue International's (GRUSF) quarterly Goodwill came in at $245339.0 in Q4 2022, little changed year-on-year from $245339.0 in Q4 2021, and little changed quarter-over-quarter from $245339.0 in Q4 2021.
Grown Rogue International (GRUSF) Goodwill (2021 - 2022) Analysis & Trends
Grown Rogue International's Goodwill history runs 2 years deep, the most recent figure standing at $245339.0 for Q4 2022.
- On a quarterly basis, Goodwill changed 0.0% year-over-year to $245339.0 in Q4 2022; TTM through Oct 2022 was $245339.0, a 0.0% change from a year earlier, with the FY2022 full-year figure at $245339.0, changed 0.0% from the prior year.
- Goodwill was little changed at $245339.0 in Q4 2022 per GRUSF's latest filing, from $245339.0 in the prior quarter.
- Across five years, Goodwill topped out at $245339.0 in Q4 2021 and bottomed at $245339.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2022 | 245,339.00 |
| Oct 31, 2021 | 245,339.00 |